Novavax's COVID vaccine brought in sales of $38.21 million ... that Donald Trump as U.S. president will be a boon for ...

But what about vaccines from Moderna and Novavax? Here's what we know. Australia's medicines watchdog has approved Pfizer's new COVID-19 vaccine and it's set to be available in the coming months.

Novavax, Inc. (NASDAQ:NVAX) Q3 2024 Earnings Call Transcript ... The trial will enroll adults aged 65 years and older and is ...

People reporting long-COVID symptoms had elevated levels of cytokines, which are proteins the body makes to fight ...

Besides Sanofi deal for nuvaxovid, Novavax has few opportunities to generate additional revenue, which likely means its stock ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved an adapted version of the Nuvaxovid COVID-19 vaccine that targets the ...

Donald Trump's nomination of Robert F Kennedy Jr. to lead the Department of Health and Human Services sent shares of major ...

Follow all the developments as Donald Trump continues to send rumbles through Washington D.C., with his cabinet picks.

The adverse event in the earlier clinical trial involved amyotrophic lateral sclerosis, which wasn't related to vaccination.

The approval of Novavax' COVID-19 vaccine in Great Britain ... Health Organisation (WHO), as well as other countries including Australia, New Zealand, South Korea, India and Indonesia.

An abundance of evidence indicates the mRNA COVID-19 vaccines are remarkably safe and work well to protect against severe disease. But last month, the state of Florida issued updated vaccine guidance ...

Opus IVStm, the global leader in intelligent vehicle support, is excited to unveil IVS Mobile, an advanced mobile diagnostic app designed to deliver OEM-level diagnostics and expert support for ...